drugset / Trial / NCT05215990

Efficacy of Metformin for Sputum Conversion in Patients With Active Pulmonary Tuberculosis

NCT05215990

RandomizedParallel-groupDouble-blindTreatment

Summary

This study was a randomized controlled trial studying about acid-fast bacillus sputum conversion ratio from positive to negative of pulmonary tuberculosis patients between metformin with pulmonary tuberculosis standard treatment group and placebo drug with pulmonary tuberculosis standard treatment.

Timeline

Start
2022-01-15
Primary completion
2022-12-31
Completion
2023-03-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Metformin Small molecule 500 mg Oral